z-logo
Premium
Sequential injection chromatographic determination of paracetamol, caffeine, and acetylsalicylic acid in pharmaceutical tablets
Author(s) -
Šatínský Dalibor,
Neto Isabel,
Solich Petr,
Sklenářová Hana,
Conceição M.,
Montenegro B. S. M.,
Araújo Alberto N.
Publication year - 2004
Publication title -
journal of separation science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.72
H-Index - 102
eISSN - 1615-9314
pISSN - 1615-9306
DOI - 10.1002/jssc.200301644
Subject(s) - repeatability , chromatography , chemistry , high performance liquid chromatography , caffeine , acetonitrile , detection limit , injection port , reproducibility , benzoic acid , dosage form , phosphate buffered saline , materials science , endocrinology , medicine , organic chemistry , composite material
In this contribution, a new separation method for simultaneous determination of paracetamol, caffeine, acetylsalicylic acid, and internal standard benzoic acid was developed based on a novel reversed‐phase sequential injection chromatography (SIC) technique with UV detection. A Chromolith® Flash RP‐18e, 25‐4.6 mm column (Merck, Germany) and a FIAlab® 3000 system (USA) with an 8‐port selection valve and a 5 mL syringe were used for sequential injection chromatographic separations in our study. The mobile phase used was acetonitrile‐(0.01 M) phosphate buffer (10 : 90, v/v ) pH 4.05, flow rate 0.6 mL min –1 . UV detection was at 210 and 230 nm. The validation parameters showed good results: linearity ( r >0.999) for all compounds, detection limits in the range 0.3–0.8 μg mL –1 , repeatability (RSD) of peak heights between runs in the range 1.10–4.30% at three concentration levels and intra‐day repeatability of the retention times in the range 0.28–0.43%. The analysis time was < 6 min. The method was found to be applicable for the routine analysis of the active compounds paracetamol, caffeine, and acetylsalicylic acid in pharmaceutical tablets.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here